Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers.
about
CYP2C19 polymorphism influences Helicobacter pylori eradicationDrug target identification using side-effect similarityPharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pyloriCYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
P2860
Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@en
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@nl
type
label
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@en
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@nl
prefLabel
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@en
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@nl
P2093
P2860
P1433
P1476
Time-dependent amplified pharm ...... e P450 2C19 poor metabolizers.
@en
P2093
Chun-Jung Lin
Herng-Der Chern
Jyh-Chin Yang
Teh-Hong Wang
Yow-Shieng Uang
P2860
P304
P356
10.1592/PHCO.23.6.711.32177
P407
P577
2003-06-01T00:00:00Z